Verastem presents two-year follow-up data for ovarian cancer therapy

Go back to Verastem presents two-year follow-up data for ovarian cancer therapy
VERASTEM SHS (NASDAQ: VSTM) Delayed: 4.21 --0 (-0%)
Previous Close $4.21    52 Week High $2.43 
Open $4.21    52 Week Low $1.05 
Day High $4.21    P/E N/A 
Day Low $4.21    EPS $-1.79 
Volume 4,679